Last reviewed · How we verify
Amoxicillin 1.0g Tab
At a glance
| Generic name | Amoxicillin 1.0g Tab |
|---|---|
| Also known as | amoxiclav |
| Sponsor | Inje University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Helicobacter Pylori Eradication Study (PHASE4)
- The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amoxicillin 1.0g Tab CI brief — competitive landscape report
- Amoxicillin 1.0g Tab updates RSS · CI watch RSS
- Inje University portfolio CI